SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Muscato Nick
(Last) (First) (Middle)
3854 AMERICAN WAY
SUITE A
(Street)
BATON ROUGE LA 70816
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
04/21/2022 		3. Issuer Name and Ticker or Trading Symbol
AMEDISYS INC [ AMED ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Strategy Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 3,402(1) D
Common Stock 213(2) I By 401(k) Plan
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (3) 07/25/2028 Common Stock 272 $95.76 D
Stock Option (Right to Buy) (4) 07/25/2029 Common Stock 320 $132.41 D
Stock Option (Right to Buy) (5) 07/25/2030 Common Stock 563 $214.74 D
Stock Option (Right to Buy) (6) 07/25/2031 Common Stock 708 $264 D
Stock Option (Right to Buy) (7) 07/25/2032 Common Stock 2,040 $143.25 D
Restricted Stock Unit (Performance-Based Vesting) (8) (8) Common Stock 1,746 (8) D
Explanation of Responses:
1. Represents restricted stock units ("RSUs") that vest based on the passage of time. 1,824 of the RSUs vest on July 25, 2022, 386 of the RSUs vest on July 25, 2023, 247 of the RSUs vest on July 25, 2024, 72 of the RSUs vest on July 25, 2025, 218 of the RSUs vest on February 20, 2023, 218 of the RSUs vest on February 20, 2024, 218 of the RSUs vest on February 20, 2025 and 219 of the RSUs vest on February 20, 2026, assuming the Reporting Person remains continuously employed by the Issuer on each such vesting date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs.
2. The information in this report is based on a plan statement dated as of March 31, 2022.
3. The Stock Options are subject to time-based vesting conditions and will vest on July 25, 2022, provided that the Reporting Person remains continuously employed by the Issuer on such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
4. The Stock Options are subject to time-based vesting conditions. 107 Stock Options vested on July 25, 2021, 107 Stock Options will vest on July 25, 2022 and 106 Stock Options will vest on July 25, 2023, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
5. The Stock Options are subject to time-based vesting conditions. 140 Stock Options vested on July 25, 2021, and 141 Stock Options will vest on each of July 25, 2022, July 25, 2023 and July 25, 2024, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
6. The Stock Options are subject to time-based vesting conditions. 177 Stock Options vest on each of July 25, 2022, July 25, 2023, July 25, 2024 and July 25, 2025, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
7. The Stock Options are subject to time-based vesting conditions. 510 Stock Options vest on each of July 25, 2023, July 25, 2024, July 25, 2025 and July 25, 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
8. The performance-based RSUs will vest based on certification of achievement of an identified performance measure for 2022, with additional time-based vesting in equal 25% installments on each of the certification date and February 20, 2024, 2025 and 2026, assuming the Reporting Person remains continuously employed on the vesting date. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.
Remarks:
Exhibit 24.1 - Power of Attorney
Jennifer Guckert Griffin, pursuant to a power of attorney 05/02/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.